Evening primrose vs borage oil: GLA content, dose and the label
Evening primrose oil and borage oil are both GLA sources, but borage carries roughly twice the GLA per gram. That changes the amount of oil or powder needed for a label figure, the ingredient name on the pack and the fatty-acid profile on the certificate. The regulatory route is broadly the same; the choice is a specification and label decision.
Borage oil carries roughly twice the GLA of evening primrose oil, so the same label figure needs about half the oil or powder weight, and a different ingredient name.
Two oils, two concentrations
Evening primrose (Oenothera biennis) seed oil typically carries 8–11% GLA, with linoleic acid at 70–75% and oleic at 8–12%. Borage (Borago officinalis) seed oil typically carries 18–23% GLA, with linoleic at 35–40%, oleic at 15–20% and palmitic at 10–12%. The GLA figure is a concentration, not a ranking: borage is more concentrated, evening primrose is more linoleic-rich.
The rest of the oil matters. A borage oil at 20% GLA is not just “twice the evening primrose” in a formulation; the lower linoleic fraction and the higher oleic and palmitic fractions change the powder's colour, taste and oxidation behaviour, and the sterol pattern is a further difference. The certificate should show the profile, not only the GLA.
The conversion behind the label figure
Start with the oil. One gram of evening primrose oil at 8–11% GLA carries 80–110 mg GLA; one gram of borage oil at 18–23% carries 180–230 mg. For a 500 mg oil capsule, that is about 40–55 mg from evening primrose and 90–115 mg from borage.
Now the powder. At a 40% oil load, one gram of evening primrose powder carries 32–44 mg GLA, and one gram of borage powder carries 72–92 mg. A 100 mg GLA serving therefore takes about 2.3–3.1 g of evening primrose powder or 1.1–1.4 g of borage powder. The carrier is the rest of the weight in both cases.
| Material | GLA concentration | Weight for 100 mg GLA |
|---|---|---|
| Evening primrose oil | 8–11% | 0.9–1.25 g |
| Borage oil | 18–23% | 0.43–0.56 g |
| Evening primrose powder, 40% oil | 3.2–4.4% on powder | 2.3–3.1 g |
| Borage powder, 40% oil | 7.2–9.2% on powder | 1.1–1.4 g |
The arithmetic uses the label figure, not a health recommendation. The serving size, the capsule fill and the number of capsules per serving decide whether the weight is practical.
The label names the source
The ingredient list must name the oil. “Oenothera Biennis Oil” and “Borago Officinalis Seed Oil” are different INCI names, and “evening primrose oil” and “borage oil” are different food names. A blend has to be declared as a blend, with the ingredients in descending order by weight; a borage oil cannot be labelled as evening primrose oil, and a blend cannot be labelled as either single oil.
The GLA figure on the label needs a basis. “100 mg GLA per serving from evening primrose oil” and “100 mg GLA per serving from borage oil” are different products with different ingredient weights. If the pack states the oil weight, the GLA figure follows from the oil's concentration; if it states the GLA figure, the oil weight follows. The two should agree with the COA.
The source also drives the front-of-pack name. A product named “Evening Primrose Oil 1000 mg” cannot be made with borage oil, even if the GLA figure is the same. A reformulation from one to the other is a new label, a new ingredient declaration and a new stability file.
The route is similar; the label is not
In the EU, both oils are food ingredients with a history of use in food supplements before 15 May 1997 and are not novel foods on that basis; confirm the current novel-food catalogue entry for the specific oil and process. Both are outside the Annex II allergen list. The food supplement rules, the contaminant limits and the claims rules apply in the same way. The UK retained framework is the same in structure, and the US route covers both as dietary ingredients.
The difference is the label, not the permission. The ingredient name, the GLA figure, the oil weight and the source statement all change. If the product carries a source-specific name or a customer specification that names the species, the other oil is a different material, not a substitute.
Claims do not follow the source. As of this review, there is no authorised health claim for evening primrose oil, borage oil or GLA in the EU or the UK, and the US structure/function route still requires the disclaimer and excludes disease claims. A higher GLA figure is not a claim.
When to choose which
Choose evening primrose when the label names evening primrose oil, when the project has an established EPO specification and an EPO stability file, and when the larger powder weight per GLA figure fits the format: a stick, a larger capsule, a tablet or an oil. Choose borage when the GLA figure has to fit a smaller powder weight, when the formula can carry the borage name, and when the customer accepts the different fatty-acid profile.
Choose neither as a drop-in. A source switch changes the ingredient name, the allergen statement, the certificate, the COA, the stability profile and possibly the taste and colour. It is a change-control event. If the project is still comparing, keep both specifications open until the label and the market file are fixed.
One more test: compare the PV and p-AV of the two oils, not only the GLA. A more concentrated GLA oil is not automatically more stable in the powder. The oil load, the antioxidant and the pack decide that.
Writing the choice into the specification
Write two separate specifications, not one with a blank source. For evening primrose: “Microencapsulated evening primrose oil powder, 40% oil load, GLA 8.0–11.0% on the oil by GC, linoleic 70–75%, carrier modified starch, PV ≤8.0 meq/kg, p-AV ≤20.0, moisture ≤4.5%, ≥95% through 40 mesh.” For borage: “Microencapsulated borage oil powder, 40% oil load, GLA 18.0–23.0% on the oil by GC, linoleic 35–40%, carrier modified starch, PV and p-AV as agreed.”
Each specification should carry the species, the INCI name, the oil load, the GLA basis, the fatty-acid profile, the carrier, the oxidation limits and the mesh. The certificate should repeat them, and the label should use the name that matches the specification. A combined “GLA powder” specification is not enough to tell the two apart.
The catalog limits are on the evening primrose oil powder product page. The certificate lines are on the COA page, the three-source comparison is on the grades page, the source evidence is on the identity page, and the label rules are on the compliance page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation